Zeng Rong, Li Min, Chen Qing, Wang Le, Zhan Ping, Wang Chong, Lv Guixia, Shen Yongnian, Liu Weida
Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China.
Antimicrob Agents Chemother. 2014;58(3):1443-50. doi: 10.1128/AAC.01007-13. Epub 2013 Dec 16.
Aspergillus fumigatus biofilms still present a challenge for effective treatment in clinical settings. While mild heat stress has been introduced as a treatment for infectious diseases, the effectiveness of mild heat stress on A. fumigatus biofilm formation and antifungal susceptibility is still unknown. In the present study, confocal laser scanning microscopy (CLSM) was used to image and quantify Aspergillus fumigatus biofilm formation under three different regimens of continuous mild heat stress: at 37, 39, and 41°C. Furthermore, fungal growth has been investigated under the above conditions in combination with antifungal drugs (amphotericin B [AMB], micafungin [MCF], and voriconazole [VOC]) at early and late stages. CLSM analysis showed that higher temperatures induce earlier germination and greater hyphal elongation but poorer polar growth and reduced biofilm thickness. In the early stage of biofilm formation, the combination of treatment at 39 or 41°C with MCF or VOC produced no visible difference in biomass formation from similar treatments at 37°C with the same drug. Interestingly, AMB treatment at 37°C inhibited early stage biofilm formation to a much greater extent than at 39 and 41°C. At the late stage of biofilm formation, the mild heat treatments at 39 and 41°C with AMB, MCF, and VOC inhibited biomass formation compared to that at 37°C. The present data show that mild heat stress has a negative regulatory effect on biofilm formation in vitro, and antifungal drug improvement with mild heat treatment at late-stage biofilm formation provides useful indications of possible effective strategies for clinical management of aspergillosis.
烟曲霉生物膜在临床环境中的有效治疗方面仍然是一个挑战。虽然温和热应激已被引入作为传染病的一种治疗方法,但温和热应激对烟曲霉生物膜形成和抗真菌药敏性的有效性仍不清楚。在本研究中,共聚焦激光扫描显微镜(CLSM)被用于对烟曲霉在三种不同的持续温和热应激方案(37、39和41°C)下的生物膜形成进行成像和定量。此外,还研究了在上述条件下,真菌在早期和晚期与抗真菌药物(两性霉素B [AMB]、米卡芬净 [MCF] 和伏立康唑 [VOC])联合生长的情况。CLSM分析表明,较高温度会诱导更早的萌发和更大的菌丝伸长,但极性生长较差且生物膜厚度减小。在生物膜形成的早期阶段,39或41°C与MCF或VOC联合处理在生物量形成方面与37°C使用相同药物的类似处理相比没有明显差异。有趣的是,37°C的AMB处理比39和41°C更能抑制早期生物膜形成。在生物膜形成的后期阶段,与37°C相比,39和41°C的温和热处理联合AMB、MCF和VOC抑制了生物量形成。目前的数据表明,温和热应激对体外生物膜形成具有负调控作用,并且在生物膜形成后期进行温和热处理来改善抗真菌药物效果,为曲霉病临床管理的可能有效策略提供了有用的指示。